This session explores how a resonance-informed, whole-plant approach to botanical development may enhance bioavailability, systemic exposure, and formulation performance beyond traditional standardized extracts. Integrating principles from Ayurvedic systems thinking with modern analytical tools such as molecular modeling and vibrational spectroscopy, this framework introduces a new lens for evaluating botanical ingredients.
We will review emerging human pharmacokinetic data demonstrating increased systemic exposure across multiple botanicals and discuss how these findings may translate into improved formulation efficiency, dosing flexibility, and product differentiation. Attendees will gain practical insight into evaluating and applying these ingredients within evidence-informed, regulatory-aware product development.
